
Sign up to save your podcasts
Or


In the first of a two part-series, Anthony and Bernie dive into the data surrounding maintenance therapies in AML. This episode focuses on maintenance therapy for patients ineligible for transplant, with a focus on oral azacitidine and the controversial QUAZAR study.
Key References:
By Bernard Marini, Anthony Perissinotti, et al.4.5
3030 ratings
In the first of a two part-series, Anthony and Bernie dive into the data surrounding maintenance therapies in AML. This episode focuses on maintenance therapy for patients ineligible for transplant, with a focus on oral azacitidine and the controversial QUAZAR study.
Key References:

38,460 Listeners

25,766 Listeners

87,160 Listeners

112,027 Listeners

56,477 Listeners

187 Listeners

10,209 Listeners

7,229 Listeners

51 Listeners

8 Listeners

15,836 Listeners

10,700 Listeners

48 Listeners

192 Listeners

621 Listeners